Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment | |
Li, Guo-Jun; Yu, Yi-Qi; Chen, Shao-Long; Fan, Ping; Shao, Ling-Yun; Chen, Jia-Zhen; Li, Chang-Shui; Yi, Bin; Chen, Wei-Cun; Xie, Shu-Yuan | |
刊名 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
![]() |
2015 | |
卷号 | 59期号:7 |
ISSN号 | 0066-4804 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4875917 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Li, Guo-Jun,Yu, Yi-Qi,Chen, Shao-Long,et al. Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,2015,59(7). |
APA | Li, Guo-Jun.,Yu, Yi-Qi.,Chen, Shao-Long.,Fan, Ping.,Shao, Ling-Yun.,...&Zhang, Wen-Hong.(2015).Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,59(7). |
MLA | Li, Guo-Jun,et al."Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment".ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 59.7(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论